Skip to main content

Cordani David's Form 4 filing

Cigna Group (CI) · filed Apr 22, 2022

Accession no.
0001225208-22-006046
Filed
Apr 22, 2022
Trade date
Apr 20-21, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $12.2M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Cordani DavidCIK 0001318751Director, Officer (Chairman & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 20, 2022Common Stock, $.01 Par ValueMOption exerciseAcquired+53,004$120.90+$6,408,183.6198,130Direct
Apr 20, 2022Common Stock, $.01 Par ValueSSaleDisposed−1,300$266.38F2−$346,294196,830Direct
Apr 20, 2022Common Stock, $.01 Par ValueSSaleDisposed−5,155$265.33F3−$1,367,776.15191,675Direct
Apr 20, 2022Common Stock, $.01 Par ValueSSaleDisposed−7,650$267.83F4−$2,048,899.5184,025Direct
Apr 20, 2022Common Stock, $.01 Par ValueSSaleDisposed−8,741$269.27F5−$2,353,689.07175,284Direct
Apr 20, 2022Common Stock, $.01 Par ValueSSaleDisposed−22,534$268.46F6−$6,049,477.64152,750Direct
Apr 21, 2022Common Stock, $.01 Par ValueMOption exerciseAcquired+7,749$120.90+$936,854.1160,499Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 20, 2022Common Stock, $.01 Par ValueMOption exerciseDisposed−53,004$0.00$060,879Direct
Apr 21, 2022Common Stock, $.01 Par ValueMOption exerciseDisposed−7,749$0.00$053,130Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average price of the shares sold. The prices actually received ranged from $266.00 to $266.98 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F3

Represents the weighted average price of the shares sold. The prices actually received ranged from $265.00 to $265.97 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F4

Represents the weighted average price of the shares sold. The prices actually received ranged from $267.07 to $267.99 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F5

Represents the weighted average price of the shares sold. The prices actually received ranged from $269.00 to $269.68 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F6

Represents the weighted average price of the shares sold. The prices actually received ranged from $268.00 to $268.99 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)